Amphastar Pharma (NASDAQ:AMPH) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here’s what investors need to know before the announcement.
Analysts estimate that Amphastar Pharma will report an earnings per share (EPS) of $0.91.
Anticipation surrounds Amphastar Pharma’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Performance in Previous Earnings
Last quarter the company beat EPS by $0.14, which was followed by a 0.83% drop in the share price the next day.
Here’s a look at Amphastar Pharma’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.79 | 0.70 | 0.69 | 0.94 |
| EPS Actual | 0.93 | 0.85 | 0.74 | 0.92 |
| Price Change % | -0.83 | 10.13 | 0.90 | -9.72 |
Tracking Amphastar Pharma’s Stock Performance
Shares of Amphastar Pharma were trading at $27.67 as of February 24. Over the last 52-week period, shares are down 12.54%. Given that these returns are generally negative, long-term shareholders are likely a …